Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Netarsudil (Primary) ; Timolol
- Indications Glaucoma; Ocular hypertension
- Focus Adverse reactions; Registrational
- Acronyms Rocket 3
- Sponsors Aerie Pharmaceuticals
- 20 Sep 2017 According to an Aerie Pharmaceuticals media release, enrollment of this trial was discontinued.
- 12 Apr 2017 Status changed from active, no longer recruiting to completed, according to an Aerie Pharmaceuticals media release.
- 24 Aug 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.